Skip to main content

Table 4 Abnormal CNVs in fetuses with ultrasonic soft marker

From: Evaluation of chromosomal abnormalities and copy number variations in fetuses with ultrasonic soft markers

Case

Indication

SNP array

Interpretation

Size Mb

Outcome

Inheritance

1

Short femur

arr[hg19]17q21.31(41,774,473–42,491,805) × 4

P

0.7

TP

Denovo

2

Short femur

arr[hg19] 10q21.3(68,972,662–69,925,900) × 1

P

0.9

TP

Denovo

3

Short femur

arr[hg19]4q28.3q31.3(133,718,289–154,569,367)hmz

VUS

20.8

TD

–

4

Short femur

arr[hg19] 15q13.3(32,003,537–32,444,043) × 3

VUS

0.4

TP

Denovo

5

Thickened nuchal translucency

arr[hg19]22q11.21(18,648,855–21,459,713) × 3

P

2.8

TP

Maternal

6

Thickened nuchal translucency

arr[hg19]Yq11.222q11.223(20,252,055–25,863,576) × 0

P

5.6

TP

Denovo

7

Thickened nuchal translucency

arr[hg19] 22q11.21(18,648,855–21,800,471) × 3

p

3.1

TP

Denovo

8

Thickened nuchal translucency

arr[hg19] 3q29(195,678,474–197,340,833) × 1

p

1.6

TP

Denovo

9

Thickened nuchal translucency

arr[hg19] 1p31.3(61,886,890–63,701,576) × 1

P

1.8

TP

Denovo

10

Thickened nuchal translucency

arr[hg19] 22q11.21(20,730,143–21,800,471) × 3

P

1.0

TP

Denovo

11

Thickened nuchal translucency

arr[hg19]1q21.1q21.2(145,829,473–148,520,164) × 1

P

2.7

TP

Denovo

12

Thickened nuchal translucency

arr[hg19]22q11.21(20,716,876–21,800,471) × 1

p

1.0

TP

Denovo

13

Thickened nuchal translucency

arr[hg19] 16p13.11(14,910,158–16,508,123) × 1

P

1.6

TP

Denovo

14

Thickened nuchal translucency

arr[hg19] Xp22.31(6,449,836–8,141,076) × 0, (XY) × 1

P

1.7

TP

Denovo

15

Thickened nuchal translucency

arr[hg19] Xq28(153,560,562–153,826,362) × 3

P

0.3

TP

Denovo

16

Thickened nuchal translucency

arr[hg19] 2p16.1(55,993,333–60,450,583) × 3

VUS

4.5

TD

–

17

Thickened nuchal translucency

arr[hg19] 19q13.42(53,717,606–54,656,213) × 3

VUS

0.9

TD

Denovo

18

Thickened nuchal translucency

arr[hg19]Xq23(109,823,197–110,252,333) × 3

VUS

0.4

TD

–

19

Thickened nuchal translucency

arr[hg19] 15q13.3(32,003,537–32,444,043) × 3

VUS

0.4

TD

Denovo

20

Thickened nuchal translucency

arr[hg19] 10q21.1(53,477,821–55,138,122) × 3

VUS

1.7

TD

Denovo

21

Thickened nuchal translucency

arr[hg19] 9q31.3(113,177,821–113,544,998) × 1

VUS

0.4

TD

–

22

Thickened nuchal translucency

arr[hg19] 1q21.1q21.2(144,077,593–148,750,533) hmz

arr[hg19] 3p21.31p21.1(48,166,782–53,172,233) hmz

arr[hg19] 5q21.3q22.1(107,196,975–110,478,806) hmz

arr[hg19] 12q21.31q21.33(82,446,525–91,707,400) hmz

arr[hg19] 14q31.2q32.12(84,339,970–92,755,472) hmz

arr[hg19] 15q24.1q25.3(73,065,223–87,467,262) hmz

arr[hg19] 16p13.3(94,807–3,112,982) hmz

arr[hg19] 17p12p11.2(15,838,698–22,170,994) hmz

VUS

99

TD

–

23

Ventriculomegaly

arr[hg19]16p11.2(29,567,296–30,190,029) × 1

P

0.6

TP

Denovo

24

Ventriculomegaly

arr[hg19]5q35.2q35.3(175,416,095–177,482,506) × 1

P

2.0

TP

Denovo

25

Ventriculomegaly

arr[hg19]Xq28(152,446,333–153,581,657) × 3, 1p36.33p36.23(849,466–592,172) × 1, 1q44(246,015,892–249,224,684) × 3

P

1.1, 7.7, 3.2

TP

Denovo

26

Ventriculomegaly

arr[hg19]1q21.1(145,375,770–145,770,627) × 1, 9p24.1(4,623,660–5,501,699) × 3

P

0.7, 0.9

TP

Denovo

27

Ventriculomegaly

arr[hg19]3p22.1 (42,875,130–43,309,436) × 1

VUS

0.4

TP

Denovo

28

Ventriculomegaly

arr[hg19]2q36.1q36.2(224,459,152–225,330,583) × 3

VUS

0.9

TD

Denovo

29

Ventriculomegaly

arr[hg19]3p26.3(1,855,754–2,663,625) × 1

VUS

0.8

TD

–

30

Ventriculomegaly

arr[hg19] 16p13.11(15,058,820–16,309,046) × 3

VUS

1.3

TD

–

31

Absent nasal bone

arr[hg19]15q13.2q13.3(30,386,398–32,444,261) × 1

P

2.0

TP

Denovo

32

Absent nasal bone

arr[hg19]16p12.2(21,816,542–22,710,614) × 1

P

1.0

TP

Denovo

33

Absent nasal bone

arr[hg19] 15q13.3(32,021,609–32,444,043) × 3

VUS

0.4

TD

Denovo

34

Absent nasal bone

arr[hg19] 15q11.2(22,770,421–23,276,833) × 1

VUS

0.5

TD

Paternal

35

Absent nasal bone

arr[hg19] 16p13.13p13.12(11,528,493–12,934,811) × 3

VUS

1.4

TD

Maternal

36

Hyperechogenic bowel

arr[hg19]22q13.33(49,683,904–51,197,766) × 1

P

3.1

TP

Denovo

37

Hyperechogenic bowel

arr[hg19]10q11.21q11.22(42,433,738–48,006,310) × 1

P

5.5

TP

Denovo

38

Hyperechogenic bowel

arr[hg19]16p13.11(15,171,146–16,309,046) × 3

VUS

1.1

TD

Paternal

39

Choroid plexus cyst

arr[hg19]22q11.21(18,648,855–21,800,471) × 1

P

3.1

TP

Maternal

40

Choroid plexus cyst

arr[hg19] 15q13.3(32,011,458–32,444,043) × 3

VUS

0.4

TD

–

41

Choroid plexus cyst

arr[hg19]8p23.2(3,703,883–5,940,433) × 3

VUS

2.2

TD

–

42

Choroid plexus cyst

arr[hg19] 20q13.2(53,545,723–54,866,110) × 3

VUS

1.3

TD

Denovo

43

Mild tricuspid regurgitation

arr[hg19] 1q21.1(145,287,532–145,966,117) × 3

P

0.7

TP

Paternal

44

Mild tricuspid regurgitation

arr[hg19]16p13.11(15,510,512–16,309,046) × 3

VUS

0.8

TD

–

45

Echogenic intracardiac focus

arr[hg19] 17q12(34,440,088–36,351,919) × 3

P

1.9

TP

Paternal

46

Right subclavian vagus, echogenic intracardiac focus

arr[hg19]22q11.21(18,648,855–21,800,471) × 1

P

3.1

TP

Denovo

47

Cavity of septum pellucidum, amniotic fluid is excessive

arr[hg19] 17p12(14,099,504–15,491,533) × 1

P

1.3

TP

–

48

Echogenic intracardiac focus, pyelectasis

arr[hg19] 6p21.32p21.31(32,965,747–35,234,269) × 3

P

2.2

TP

Denovo

49

Absent nasal bone, echogenic intracardiac focus

arr[hg19] 17p12(14,070,219–15,484,335) × 1

P

1.4

TP

Denovo

50

Absent nasal bone, pyelectasis

arr[hg19] 2p22.3(34,002,379–35,076,738) × 3

VUS

1.0

TD

–

51

Mild tricuspid regurgitation, pericardial effusion

arr[hg19]5p15.33p15.31(4,482,234–6,636,035) × 1

P

2.1

TP

Denovo

52

Short femur, hyperechogenic bowel

arr[hg19]10q11.22q11.23(46,252,072–51,903,756) × 1

P

5.6

TP

–

53

Mild tricuspid regurgitation, hyperechogenic bowel

arr[hg19]15q11.2(22,770,421–23,286,423) × 1

VUS

0.5

TD

Paternal

54

Mild tricuspid regurgitation, echogenic intracardiac focus

arr[hg19] 15q11.2(22,770,421–23,277,436) × 1

VUS

0.5

TD

Denovo

55

Mild tricuspid regurgitation, echogenic intracardiac focus

arr[hg19] Xp22.33 or Yp11.32(387,396–629,998 or 337,396–579,998) × 1

P

0.2

TP

Denovo

56

Echogenic intracardiac focus, ventriculomegaly

arr[hg19] 16p13.11(15,422,960–16,508,123) × 1

P

1.0

TP

Denovo

57

Single umbilical artery, mild tricuspid regurgitation

arr[hg19] 1q21.1q21.2(145,084,525–147,885,600) × 1

P

2.8

TP

Paternal

58

Echogenic intracardiac focus, mild tricuspid regurgitation

arr[hg19] Xp22.33 or Yp11.32(168,551–629,999 or 118,551–579,999) × 1

P

0.5

TP

Denovo

59

Hyperechogenic bowel, mild tricuspid regurgitation

arr[hg19] 16p13.11(15,058,820–16,309,046) × 3

VUS

1.25

TD

Denovo

60

Hyperechogenic bowel, enlargement of intestinal canal

arr[hg19] 16p13.11(14,900,042–16,508,123) × 3

VUS

1.6

TD

Denovo

61

Ventriculomegaly, choroid plexus cyst

arr[hg19]14q21.2q21.3(46,782,405–49,288,860) × 1

VUS

2.5

TP

–

62

Ventriculomegaly, short femur

arr[hg19]3q26.1q29(163,256,369–197,791,601)hmz

arr[hg19]5p13.1p11(41,029,137–46,313,469)hmz

arr[hg19]6q24.2q25(143,341,406–161,527,784)hmz

arr[hg19]12q13.2q21.2(56,011,100–77,134,151)hmz

arr[hg19]17q21.2q21.32(39,639,602–45,479,706)hmz

arr[hg19]21q21.3q22.2(28,124,165–42,352,287)hmz

VUS

99.1

TD

–

63

Ventriculomegaly, echogenic intracardiac focus

arr[hg19]10q24.31q24.32(102,972,457–103,179,063) × 3

VUS

0.2

TD

Denovo

64

Mild tricuspid regurgitation, pyelectasis

arr[hg19]13q14.3(52,649,105–53,172,866) × 3

VUS

0.5

TD

–

65

Thickened nuchal translucency, thickening of skin in chest and abdomen

arr[hg19]1p33p32.3(50,051,514–53,274,566) hmz

arr[hg19]2q23.3q24.1(153,771,280–158,783,675) hmz

arr[hg19]3q21.2q22.1(124,817,983–129,317,745) hmz

arr[hg19]3q22.1q23(133,262,566–139,418,898) hmz

arr[hg19]3q26.1q26.2(161,540,639–168,592,236) hmz

arr[hg19]7p22.3p21.2(2,707,569–13,857,235) hmz

arr[hg19]8q23.3q24.12(114,788,423–119,897,611) hmz

arr[hg19]9p22.1p13.3(19,696,747–36,125,149) hmz

arr[hg19]11q12.2q12.3(60,193,879–63,210,491) hmz

arr[hg19]11p11.2p11.21(45,781,075–51,550,787) hmz

arr[hg19]17q21.31q21.32(41,647,165–44,927,874) hmz

arr[hg19]17q25.1q25.3(71,965,953–75,785,426) hmz

arr[hg19]20p11.23p11.21(20,268,153–23,275,237) hmz

VUS

77.5

–

–

66

Thickened nuchal translucency, echogenic intracardiac focus, mild tricuspid regurgitation, hyperechogenic bowel

arr[hg19] 18q21.33q22.1(60,147,532–65,974,912) × 1 hmz

P

5.8

TP

–

67

Echogenic intracardiac focus, mild tricuspid regurgitation, pyelectasis

arr[hg19] 6q21(106,385,070–109,072,236) × 3

VUS

2.6

TD

Denovo

68

Ventriculomegaly, hyperechogenic bowel, echogenic intracardiac focus

arr[hg19]16p11.2(28,810,324–29,032,280) × 1

P

0.2

TP

–

69

Echogenic intracardiac focus, mild tricuspid regurgitation, short femur

arr[hg19] 22q11.21(21,059,669–21,800,471) × 1

P

0.4

TP

Denovo

  1. CNVs abnormal copy number variations, P pathogenic, TD term delivery, TP termination of pregnancy, VUS variation of uncertain clinical significance